Elekta (OTCMKTS:EKTAY) Announces Earnings Results

Elekta (OTCMKTS:EKTAYGet Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, Zacks reports. Elekta had a net margin of 1.40% and a return on equity of 11.49%.

Elekta Stock Up 24.2%

Shares of Elekta stock traded up $1.12 on Wednesday, reaching $5.73. 14,014 shares of the company were exchanged, compared to its average volume of 11,135. The company has a current ratio of 1.05, a quick ratio of 0.82 and a debt-to-equity ratio of 0.63. Elekta has a one year low of $4.35 and a one year high of $6.29. The company has a 50-day moving average of $4.96 and a 200 day moving average of $5.01. The company has a market capitalization of $2.11 billion, a price-to-earnings ratio of 95.52 and a beta of 1.12.

Elekta Announces Dividend

The business also recently declared a dividend, which was paid on Friday, September 26th. Investors of record on Tuesday, September 9th were given a dividend of $0.0744 per share. The ex-dividend date of this dividend was Monday, September 8th. This represents a yield of 289.0%. Elekta’s dividend payout ratio is 200.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on EKTAY shares. UBS Group started coverage on shares of Elekta in a research note on Wednesday, September 3rd. They issued a “sell” rating for the company. Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 16th. Three equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce”.

Check Out Our Latest Analysis on Elekta

Elekta Company Profile

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Featured Stories

Earnings History for Elekta (OTCMKTS:EKTAY)

Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.